Drug Shortage Report for SANDOZ LATANOPROST

Last updated on 2022-06-04 History
Report ID 160292
Drug Identification Number 02367335
Brand name SANDOZ LATANOPROST
Common or Proper name LATANOPROST
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) LATANOPROST
Strength(s) 50MCG
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 2.5ML LDP
ATC code S01EE
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-05-10
Estimated end date 2022-06-10
Actual end date 2022-06-03
Shortage status Resolved
Updated date 2022-06-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-06-04 English Compare
v4 2022-06-03 French Compare
v3 2022-06-03 English Compare
v2 2022-05-10 French Compare
v1 2022-05-10 English Compare

Showing 1 to 5 of 5